943596-70-1 Usage
Explanation
The compound has 13 carbon atoms, 18 hydrogen atoms, and 3 oxygen atoms.
Explanation
The compound is derived from butenone, which is a four-carbon compound with a carbonyl group at one end and a double bond at the other. It has a phenyl group (C6H5) attached to it, along with two ether groups (R-O-R').
Explanation
The stereochemistry of the compound is important for its chemical and biological behaviors. The "1t" indicates the presence of a specific stereoisomer, which can affect the compound's properties and applications.
Explanation
Due to its unique structure and potential biological activities, the compound is used in various fields, including the synthesis of organic compounds, pharmaceutical research, and the production of aromatic substances for fragrances and flavors.
Explanation
The compound's unique structure and stereochemistry may give it specific biological activities, making it a candidate for further research and development in the pharmaceutical industry.
Explanation
The compound's chemical behavior, such as its reactivity and stability, is largely determined by its stereochemistry, which can affect how it interacts with other molecules and compounds.
Structure
Butenone derivative with a phenyl group and two ether substituents
Stereochemistry
1t-(3-methoxy-4-ethoxy-phenyl)-buten-1-one-3
Applications
Organic synthesis, pharmaceutical research, fragrances, and flavors
Aromatic Properties
Utilized in the production of fragrances and flavors
Biological Activities
Potential for pharmaceutical research
Chemical Behavior
Influenced by stereochemistry
Check Digit Verification of cas no
The CAS Registry Mumber 943596-70-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,5,9 and 6 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 943596-70:
(8*9)+(7*4)+(6*3)+(5*5)+(4*9)+(3*6)+(2*7)+(1*0)=211
211 % 10 = 1
So 943596-70-1 is a valid CAS Registry Number.
943596-70-1Relevant academic research and scientific papers
ARYLAMINE KETONES, THEIR PREPARATION METHODS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
-
Page/Page column 12, (2010/11/27)
Disclosed Arylamine ketones of formula (I), their preparation methods, the pharmaceutical compositions containing them and their use in preventing and/or treating the diseases related to the plaque-activating factors, especially in anti-inflammation and immunization, more especially in the treatment of the acute or chronic inflammation, such as, osteoarthritis, oarthritis deformans, etc..
Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents
Tatsuzaki, Jin,Bastow, Kenneth F.,Nakagawa-Goto, Kyoko,Nakamura, Seiko,Itokawa, Hideji,Lee, Kuo-Hsiung
, p. 1445 - 1449 (2008/12/21)
Twenty-eight compounds related to dehydrozingerone (1), isoeugenol (3), and 2-hydroxychalcone (4) were synthesized and evaluated in vitro against human tumor cell replication. Except for isoeugenol analogues 27-35, most compounds exhibited moderate or strong cytotoxic activity against KB, KB-VCR (a multidrug-resistant derivative), and A549 cell lines. In particular, chalcone 15 showed significant cytotoxic activity against the A549 cell line with an IC50 value of 0.6 μg/mL. Furthermore, dehydrozingerone analogue 11 and chalcones 16 and 17 showed significant and similar cytotoxic activity against both KB (IC50 values of 2.0, 1.0, and 2.0 μg/mL, respectively) and KB-VCR (IC50 values of 1.9, 1.0, and 2.0 μ/mL, respectively) cells, suggesting that they are not substrates for the P-glycoprotein drug efflux pump.
